Rare Ovarian Cancers: Research Updates
Every year, more than 22,000 people are diagnosed with ovarian cancer. Most (85% – 90%) will be diagnosed with a form of epithelial ovarian cancer; and among these, most will … Continued
News
New Study Highlights Importance of Mental Health Support for Ovarian Cancer Patients
Researchers at the University of Utah and Huntsman Cancer Institute found that an ovarian cancer diagnosis took a much higher mental toll on patients and survivors than initially expected at the … Continued
Vulnerability in ARID1A-Mutant Cancer Cells Could Provide New Pathways for OCCC Treatment
OCRA grantees Dr. Rugang Zhang and Dr. Shuai Wu, both of The Wistar Institute, along with colleagues, have discovered a vulnerability in cancer cells that harbor certain genetic mutations. Their findings, which involve … Continued
OCRA Awards Prizes in Ovarian Cancer Research
Each year, OCRA honors individuals doing important and notable work in the ovarian cancer field with a research prize to help propel their future discoveries. Individuals are selected by members … Continued
A False Alarm, and a Wake-Up Call to Fight Ovarian Cancer
Imagine, if you will, a scene from yesteryear: rows of telephone operators sitting in front of giant switchboards, lights blinking on and off in seemingly random patterns, hands working quickly … Continued
Xueyang Yu, PhD., Ovarian Cancer Researcher | Meet a Scientist
Dr. Xueyang Yu, of Massachusetts Institute of Technology, is a 2021 recipient of OCRA’s Ann and Sol Mentored Investigator Award. Her project, “Macrophage Control of the Microenvironment Drives HGSOC Progression,” … Continued
The Overview: February 2021
We have great hope for the year ahead, and much of that is buoyed by what we accomplished, with your help, in 2020. A quick look back at the numbers… … Continued
Racial Disparities in Ovarian Cancer are Real
Dr. Dineo Khabele, Professor and Chair of the Department of Obstetrics & Gynecology at Washington University School of Medicine in St. Louis and member of OCRA’s Scientific Advisory Committee, spoke … Continued
OCRA Awards Millions in New Ovarian Cancer Research Grants
Despite the challenges of fundraising during a global pandemic, your generous support allowed us to fund 16 top scientists at 14 esteemed medical centers across the globe. They will investigate … Continued
OCRA-Funded Research Provides a New Understanding of Ovarian Cancer Biology
OCRA-funded researcher Anil K. Sood, M.D., lead and senior author, and Sanghoon Lee, Ph.D., first author, both at MD Anderson Cancer Center, along with colleagues, identified potential biomarkers in subgroups of … Continued
The COVID-19 Vaccine and Ovarian Cancer: Resources and Information
The rollout of COVID-19 vaccines in the United States has many feeling hopeful about the possibility of gaining some protection against the virus. But as with any new medical advancement, … Continued
Oral Contraceptives Tied to Lower Long-Term Ovarian Cancer Risk
A recent study, published in Cancer Research and reported in The New York Times, suggests that risk-reduction associated with oral contraceptive use can last a lifetime. The link between lower … Continued